🕵️ Diamedica Therapeutics Inc. ($DMAC)
SEC insider & ownership activity, last 12 months · CIK 1401040 · every row links its SEC filing
Over the last 12 months insiders bought $7.6M with no open-market selling against it. Stahlberg Jan bought $7.6M (Nov). Leon G. Cooperman added 6.3% → 6.6%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $7.6M (7 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Stahlberg Jan | 7 | $7.6M | 0 | – | Nov 25, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Trill Ab | 16.9% | 13G | Feb 6, 2026 | filing ↗ | |
| Jan Stahlberg | 16.9% | 13G | Feb 6, 2026 | filing ↗ | |
| TomEnterprise Ab | 16.3% | 13G | Jul 30, 2025 | filing ↗ | |
| TomEnterprise Private Ab | 16.3% | 13G | Jul 30, 2025 | filing ↗ | |
| Thomas Von Koch | 16.3% | 13G | Jul 30, 2025 | filing ↗ | |
| Trill Ab | 15.0% | 13G | Sep 4, 2025 | filing ↗ | |
| Richard Jacinto II | 9.6% | 13G | Nov 7, 2025 | filing ↗ | |
| Leon G. Cooperman | 6.6% | 13G | Feb 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 20, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Jan 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing ↗ |
| Other events (8.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |